BioLife Solutions to be acquired by Repligen in $1.5B cell therapy deal

BioLife Solutions, a Bothell, Wash.-based company developing tools for cell and gene therapy, is being acquired for $1.5 ...

Repligen beefs up cell therapy business with $1.5 billion deal for BioLife

By Sahil Pandey July 22 (Reuters) - Repligen Corp said on Wednesday it would buy BioLife Solutions in a cash-and-stock deal ...

Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media

Fast-tracks Repligen’s leadership and customer solution offering in high-growth cell therapy market by adding BioLife’s ...

Repligen to Expand Cell Therapy Capabilities With BioLife Buyout

Repligen CorporationRGEN announced that it has entered into a definitive agreement to acquire Washington-based BioLife SolutionsBLFS, a leading developer of bioproduction products ...
News Medical

BioLife reports increased use of CryoStor and HypoThermosol biopreservation media products in clinical studies

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related ...